PERCF (Percheron Therapeutics) Institutional Ownership: 0.03% (As of Jul. 01, 2026)


What is Percheron Therapeutics Institutional Ownership?

Percheron Therapeutics PERCF -0.18% Institutional Ownership is 0.03% as of Jul. 01, 2026. The stock has 2 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Percheron Therapeutics's institutional ownership is 0.03%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Percheron Therapeutics's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Percheron Therapeutics's Float Percentage Of Total Shares Outstanding is 0.00%.

Percheron Therapeutics Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Percheron Therapeutics's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Percheron Therapeutics Institutional Ownership Chart

Percheron Therapeutics Historical Data

The historical data trend for Percheron Therapeutics can be seen below:

2025-08-31 2025-09-30 2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31
Institutional Ownership 8.64 8.64 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02

Percheron Therapeutics Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 0.03% mean?
Percheron Therapeutics (PERCF) has a Institutional Ownership of 0.03% as of Jul. 01, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Percheron Therapeutics and its competitors.
Is Percheron Therapeutics' Institutional Ownership too high?
Percheron Therapeutics' current Institutional Ownership is 0.03%.
How does Percheron Therapeutics' Institutional Ownership compare to ZTS and UTHR?
Percheron Therapeutics' Institutional Ownership of 0.03% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Drug Manufacturers company?
A good Institutional Ownership depends on the Drug Manufacturers industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Percheron Therapeutics and its competitors. Percheron Therapeutics's current Institutional Ownership is 0.03%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Percheron Therapeutics stock overvalued right now?
Percheron Therapeutics (PERCF) has a current Institutional Ownership of 0.03%. The current Institutional Ownership is 0.03%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Percheron Therapeutics (PERCF), the current Institutional Ownership is 0.03% as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Percheron Therapeutics Business Description

Other Exchanges AWY0:GermanyPER:Australia
Address 35 Collins Street, Level 30, Collins Place, Melbourne, VIC, AUS, 3000
Percheron Therapeutics Ltd is a biotechnology company, developing and commercializing antisense pharmaceuticals for large unmet markets in rare diseases. The company operates into two operating segment: ATL1102 and ATL1103. Key revenue is generated from ATL1102.